Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
Injections can be weekly while refills are made on follow-ups.
2A-H), we observed that intratumoral CD8 + T cell infiltration decreased with increasing folate intake, suggesting that folate might inhibit CD8 + T cell recruitment directly or indirectly
Dihexa works differentlyby recalibrating brain chemistry and supporting cellular healing , without aggressive intervention
BPC-157 Supplied strictly for laboratory, analytical, and research purposes only